2ⁿᵈ Edition of the Cancer R&D World Conference 2026

Scientific Sessions

Advances in Nanotechnology for Cancer Treatment

Nanotechnology transforms cancer treatment through targeted drug delivery, minimizing side effects by focusing therapies on cancer cells. It enhances imaging with nanoparticles like quantum dots, enabling early detection and precise diagnostics. Innovative treatments such as photothermal and photodynamic therapy use nanoparticles to destroy tumors with minimal invasiveness. At the Cancer Research and Development Conference 2025, this scientific session will explore how nanotechnology is revolutionizing oncology, addressing challenges in regulation and safety. Gene therapy and theragnostic nanocarriers combine diagnostics and treatment, offering personalized, adaptive solutions. Join us as we delve into the future of nanotechnology-driven advancements in cancer research and treatment.

Related Sessions

Current Landscape and Future Directions of Oncology Research
Oncogenic Signaling Pathways and Therapeutic Targets
Emerging Biomarkers for Cancer Detection and Prognosis
Cancer Prevention and Early Detection Strategies
Immuno Oncology and Cell Based Therapies
Innovations in Immuno Oncology
Cytokine Modulation and Immune Adjuvants in Cancer Immunotherapy
Cancer Vaccines
CAR T Cell Therapy: Clinical Progress and Challenges
Next Generation Cell and Gene Therapies in Oncology
Liquid Biopsy and Circulating Tumor DNA (ctDNA) Diagnostics
Companion Diagnostics
Artificial Intelligence and Machine Learning in Precision Oncology
Next Generation Targeted Therapies: KRAS, HER2, BRAF, and NRAS
Overcoming Drug Resistance: Mechanisms and Solutions
Oncology Pipeline
Trends in Antibody Drug Conjugates (ADCs)
Launch of Novel mAb Products for Cancer Therapy